Shuttle Pharmaceuticals Holdings, Inc.
SHPHShuttle Pharmaceuticals is a pharmaceutical technology company focused on accelerating molecular discovery and early-stage drug development through an artificial intelligence-driven platform.
Table of contents
Earnings
Next report
Date not yet announcedCompetitors
By market cap
By revenue growth
Profile
Shuttle Pharmaceuticals is a pharmaceutical technology company focused on accelerating molecular discovery and early-stage drug development through an artificial intelligence-driven platform. The company provides an AI infrastructure layer for molecular research, utilizing predictive analytics and structured scientific workflows to improve decision-making in medicinal chemistry. Following a strategic shift, the company is transitioning from traditional clinical drug development to a software-enabled discovery model.
The company is an emerging player in the AI-driven drug discovery space, transitioning from a clinical-stage biotech to a technology-focused platform provider.
Questions, answered.
- What is Shuttle Pharmaceuticals Holdings, Inc.'s market cap?
- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has a market capitalization of $163.3K and trades on NASDAQ.
- Who are Shuttle Pharmaceuticals Holdings, Inc.'s competitors?
- Shuttle Pharmaceuticals Holdings, Inc.'s key competitors include Schrödinger, Inc., Recursion Pharmaceuticals, AbCellera Biologics, and others. These companies compete in similar markets and product categories.
- Who does Shuttle Pharmaceuticals Holdings, Inc. partner with?
- Shuttle Pharmaceuticals Holdings, Inc.'s notable partners include Nasdaq.
- What subsidiaries does Shuttle Pharmaceuticals Holdings, Inc. have?
- Shuttle Pharmaceuticals Holdings, Inc.'s subsidiaries include Shuttle Pharmaceuticals, Inc..
- Where is Shuttle Pharmaceuticals Holdings, Inc. headquartered?
- Shuttle Pharmaceuticals Holdings, Inc. is headquartered in United States of America and employs approximately 8 people. It has been publicly traded since 2022.